Related Experiment Video
Updated: Nov 7, 2025

09:31
Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
Published on: January 27, 2023
1.2K
Protective factors against preterm infants to develop significant patent ductus arteriosus
Hsiao-Wen Huang1, Chih Lin1, Kai-Hsiang Hsu2
1Division of Neonatology, Department of Pediatrics, Chang Gung Memorial Hospital Linkou Branch, Taoyuan, Taiwan.
Pediatrics and Neonatology
|May 1, 2021
Summary
A new scoring system predicts spontaneous closure of patent ductus arteriosus (PDA) in preterm infants within the first week of life. This tool aids clinicians in managing PDA by assessing gestational age, oxygen index, and intubation needs.
Area of Science:
- Neonatology
- Pediatric Cardiology
- Medical Informatics
Background:
- Patent ductus arteriosus (PDA) closure is crucial for preterm infants.
- Predicting spontaneous PDA closure aids in clinical management.
- Very low birthweight (VLBW) infants require careful monitoring for PDA.
Purpose of the Study:
- To assess daily PDA status in VLBW preterm infants during their first week of life.
- To develop a predictive scoring system for spontaneous PDA closure.
- To identify factors influencing PDA closure in preterm neonates.
Main Methods:
- Daily echocardiographic screening for PDA in VLBW infants.
- Utilized Oxygen Index (OI) to represent respiratory status.
- Developed a scoring system based on gestational age (GA), OI, and endotracheal intubation needs.
Main Results:
- Spontaneous PDA closure by 1 week occurred in 80% (GA ≥30 wks), 70% (28-29 wks), and 34% (≤27 wks).
- Factors associated with closure included higher GA, lower OI (<2.5), and less need for intubation.
- A scoring system (GA, OI, intubation) achieved 77% sensitivity and 72% specificity for predicting closure.
Conclusions:
- A novel scoring system effectively predicts spontaneous PDA closure in preterm infants.
- The score integrates GA, OI, and intubation status for clinical utility.
- This tool can assist clinicians in optimizing PDA management strategies for VLBW neonates.

